Search
for
Sort by
Research 361–390 of 410
- Dermatopathia pigmentosa reticularis: A report of a case with delayed onset alopecia and onychodystrophy
- Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action
- Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
- Lasers, lights, and compounds for hair loss in aesthetics
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Bone marrow-derived vasculogenesis leads to scarless regeneration in deep wounds with periosteal defects
- Hair thread tourniquet syndrome in a male infant: a rare surgical emergency
- Advanced Lipotransfer Techniques
- Transforming By-Products into Functional Resources: The Potential of Cucurbitaceae Family Seeds in Cosmetics
- Tissue Engineering in Cosmetics and Dermatology: A New Era of Innovation and Application
- Dermatologic care of patients with differences of sex development
- The Transcriptional Regulator Prdm1 Is Essential for the Early Development of the Sensory Whisker Follicle and Is Linked to the Beta-Catenin First Dermal Signal
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
- Scrotal Rejuvenation
- Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Exploration of the Possible Relationships Between Gut and Hypothalamic Inflammation and Allopregnanolone: Preclinical Findings in a Post-Finasteride Rat Model.
- The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients
- Cutaneous manifestations associated with substance use disorders
- Post-finasteride syndrome - a true clinical entity?
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Navaratnas in Dermatology